S. Keenan

发表

Structural model of the Plasmodium CDK, Pfmrk, a novel target for malaria therapeutics.

William J Welsh, Youyi Peng, Youyi Peng, 2005, Journal of molecular graphics & modelling.

Expression of Cyclin E Renders Cyclin D-CDK4 Dispensable for Inactivation of the Retinoblastoma Tumor Suppressor Protein, Activation of E2F, and G1-S Phase Progression*

Nathan H. Lents, S. Keenan, J. Baldassare, 2004, Journal of Biological Chemistry.

Stimulation of the Raf/MEK/ERK Cascade Is Necessary and Sufficient for Activation and Thr-160 Phosphorylation of a Nuclear-targeted CDK2*

Nathan H. Lents, S. Keenan, J. Baldassare, 2002, The Journal of Biological Chemistry.

Activation and Phosphorylation on Thr‐160 of Nuclear‐Targeted CDK2 Is ERK Dependent

Nathan H. Lents, S. Keenan, J. Baldassare, 2002, Annals of the New York Academy of Sciences.

Malarial kinases: novel targets for in silico approaches to drug discovery.

S. Keenan, R. K. DeLisle, Kristen M. Bullard, 2013, Methods in molecular biology.

Elucidation of the Na+, K+-ATPase digitalis binding site.

W. Welsh, S. Keenan, R. K. DeLisle, 2005, Journal of molecular graphics & modelling.

Three-dimensional structure-activity relationship modeling of digoxin inhibition and docking to Na+,K+-ATPase.

W. Welsh, S. Keenan, R. K. DeLisle, 2003, Annals of the New York Academy of Sciences.

3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.

Vladyslav Kholodovych, William J Welsh, Youyi Peng, 2005, Journal of medicinal chemistry.

Discovery of novel triazole-based opioid receptor antagonists.

Qiang Zhang, Youyi Peng, W. Welsh, 2006, Journal of medicinal chemistry.

Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.

L. Gerena, N. Waters, S. Keenan, 2009, Bioorganic & medicinal chemistry letters.

Cyclin-dependent Kinase 2 Nucleocytoplasmic Translocation Is Regulated by Extracellular Regulated Kinase*

S. Keenan, J. Baldassare, C. Bellone, 2001, The Journal of Biological Chemistry.

Purification and mass spectrometric analysis of the mu opioid receptor.

S. Keenan, Hong Li, R. Howells, 2003, Brain research. Molecular brain research.

Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323

B. Geiss, S. Keenan, Kristen M. Bullard, 2015, PloS one.

Molecular scaffold protein and cellular responses

S. Keenan, J. Baldassare, 2001, Trends in Endocrinology & Metabolism.

Hemodynamic response profile predicts susceptibility to cocaine-induced toxicity.

S. Keenan, M. Knuepfer, Q. Gan, 2003, European journal of pharmacology.

Highly potent triazole-based tubulin polymerization inhibitors.

Sonia Arora, William J Welsh, Youyi Peng, 2007, Journal of medicinal chemistry.

Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.

L. Gerena, N. Waters, W. Welsh, 2007, Bioorganic & medicinal chemistry letters.

Identification of a Novel Antiviral Inhibitor of the Flavivirus Guanylyltransferase Enzyme

B. Geiss, S. Keenan, B. Saeedi, 2012, Journal of Virology.

Analysis of flavivirus NS5 methyltransferase cap binding.

A. Thompson, B. Geiss, S. Keenan, 2009, Journal of molecular biology.

Influence of the structural diversity of data sets on the statistical quality of three-dimensional quantitative structure-activity relationship (3D-QSAR) models: predicting the estrogenic activity of xenoestrogens.

Weida Tong, William J Welsh, W. Tong, 2002, Chemical research in toxicology.

Requirement of Activated Cdc42-Associated Kinase for Survival of v-Ras-Transformed Mammalian Cells

W. Welsh, S. Keenan, S. Meiners, 2005, Molecular Cancer Research.

Novel microtubule polymerization inhibitor with potent antiproliferative and antitumor activity.

Qiang Zhang, Youyi Peng, W. Welsh, 2009, Cancer research.

Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.

N. Waters, S. Keenan, Susan M Keenan, 2010, Infectious disorders drug targets.

A High-Throughput Screening Assay for the Identification of Flavivirus NS5 Capping Enzyme GTP-Binding Inhibitors

B. Geiss, S. Keenan, B. Saeedi, 2011, Journal of biomolecular screening.

Focus on flaviviruses: current and future drug targets.

B. Geiss, S. Keenan, Amanda M Hannah, 2009, Future medicinal chemistry.

Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species.

W S Branham, D M Sheehan, R. Perkins, 1997, Environmental health perspectives.

Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.

Qiang Zhang, Youyi Peng, W. Welsh, 2009, Bioorganic & medicinal chemistry.

Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis.

William J Welsh, Stefan Paula, W. Welsh, 2003, Journal of molecular biology.

3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs.

Qiang Zhang, Youyi Peng, W. Welsh, 2005, Journal of molecular graphics & modelling.

First-generation undergraduate researchers: understanding shared experiences through stories

S. Keenan, Christine M. Henrichsen, 2023, Frontiers in Education.

Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites

S. Keenan, Carolyn J. Broccardo, Kristen M. Bullard, 2015, Malaria Journal.

Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.

W. Welsh, S. Keenan, 2004, Journal of molecular graphics & modelling.

Instructional Communities of Practice during COVID-19: Social Networks and Their Implications for Resilience†

S. Keenan, E. Holt, Daniel Z. Grunspan, 2021, Journal of microbiology & biology education.

Purification and mass spectrometric analysis of the mu opioid receptor.

S. Keenan, Hong Li, R. Howells, 2003, Brain research. Molecular brain research.